Cardiac sarcoidosis detected by late gadolinium enhancement and prevalence of atrial arrhythmias

American Journal of Cardiology

Volumn 113, Issue 9, 2014, Pages 1556-1560

  Cain, Matthew A ^a   Metzl, Mark D ^a   Patel, Amit R ^a   Addetia, Karima ^a   Spencer, Kirk T ^a   Sweiss, Nadera J ^b   Beshai, John F ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; GADOLINIUM;

ADULT; AGED; AMBULATORY MONITORING; ARTICLE; BIOPSY; CARDIOVASCULAR MAGNETIC RESONANCE; CEREBROVASCULAR ACCIDENT; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART ELECTROPHYSIOLOGY; HEART MUSCLE; HEART VENTRICLE ARRHYTHMIA; HOLTER MONITOR; HUMAN; IMAGING SYSTEM; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PATIENT ASSESSMENT; PATIENT CODING; PRIORITY JOURNAL; RECORDER; RISK BENEFIT ANALYSIS; SARCOIDOSIS; SUPRAVENTRICULAR TACHYCARDIA; TISSUE DOPPLER IMAGING; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; ANTICOAGULANTS; ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHIES; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RISK ASSESSMENT; SARCOIDOSIS; STROKE;

EID: 84898670892     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.01.434     Document Type: Article

References (14)

1. J.P. Smedema, G. Snoep, M.P. van Kroonenburgh, R.J. van Geuns, W.R. Dassen, A.P. Gorgels, and H.J. Crijnis Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis J Am Coll Cardiol 45 2005 1683 1690
2. D.A. Steckman, P.M. Schneider, J.L. Schuller, R.G. Aleong, D.T. Nguyen, G. Sinagra, G. Vitrella, F. Brun, M.A. Cova, L. Pagnan, L. Mestroni, P.D. Varosy, and W.H. Sauer Utility of cardiac magnetic resonance imaging to differentiate cardiac sarcoidosis from arrhythmogenic right ventricular cardiomyopathy Am J Cardiol 110 2012 575 579
3. A.R. Patel, M.R. Klein, S. Chandra, K.T. Spencer, J.M. Decara, R.M. Lang, M.C. Burke, E.R. Garrity, D.K. Hogarth, S.L. Archer, N.J. Sweiss, and J.F. Beshai Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational study Eur J Heart Fail 13 2011 1231 1237
4. B.P. Betensky, C.M. Tschabrunn, E.S. Zado, L.R. Goldberg, F.E. Marchlinski, F.C. Garcia, and J.M. Cooper Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators Heart Rhythm 9 2012 884 891
5. D. Mehta, N. Mori, S.H. Goldbarg, S. Lubitz, J.P. Wisnivesky, and A. Teirstein Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: role of programmed ventricular stimulation Circ Arrhythm Electrophysiol 4 2011 43 48
6. J.L. Schuller, M. Zipse, T. Crawford, F. Bogun, J. Beshai, A.R. Patel, N.J. Sweiss, D.T. Nguyen, R.G. Aleong, P.D. Varosy, H.D. Weinberger, and W.H. Sauer Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis J Cardiovasc Electrophysiol 23 2012 925 929
7. H.A. Fleming Sarcoidosis of the heart Am J Med 64 1978 915 916
8. J.F. Viles-Gonzalez, L. Pastori, A. Fischer, J.P. Wisnivesky, M.G. Goldman, and D. Mehta Supraventricular arrhythmias in patients with cardiac sarcoidosis: prevalence, predictors, and clinical implications Chest 143 2013 1085 1090
9. C. Röcken, B. Peters, G. Juenemann, W. Saeger, H.U. Klein, C. Huth, A. Roessner, and A. Goette Atrial amyloidosis: an arrhythmogenic substrate for persistent atrial fibrillation Circulation 106 2002 2091 2097
10. J. Schulz-Menger, D.A. Bluemke, J. Bremerich, S.D. Flamm, M.A. Fogel, M.G. Friedrich, R.J. Kim, F. von Knobelsdorff-Brenkenhoff, C.M. Kramer, D.J. Pennell, S. Plein, and E. Nagel Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing J Cardiovasc Magn Reson 15 2013 35
11. G.R. Vergara, and N.F. Marrouche Tailored management of atrial fibrillation using a LGE-MRI based model: from the clinic to the electrophysiology laboratory J Cardiovasc Electrophysiol 22 2011 481 487
12. J.B. Selvanayagam, P.N. Hawkins, B. Paul, S.G. Myerson, and S. Neubauer Evaluation and management of the cardiac amyloidosis J Am Coll Cardiol 50 2007 2101 2110
13. R. Tung, P. Zimetbaum, and M.E. Josephson A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death J Am Coll Cardiol 52 2008 1111 1121
14. J.E. Poole, G.W. Johnson, A.S. Hellkamp, J. Anderson, D.J. Callans, M.H. Raitt, R.K. Reddy, F.E. Marchlinski, R. Yee, T. Guarnieri, M. Talajic, D.J. Wilber, D.P. Fishbein, D.L. Packer, D.B. Mark, K.L. Lee, and G.H. Bardy Prognostic importance of defibrillator shocks in patients with heart failure N Engl J Med 359 2008 1009 1017